BridgeBio scraps plan to buy Eidos after bids rebuffed

BridgeBio scraps plan to buy Eidos after bids rebuffed

Source: 
Fierce Biotech
snippet: 

BridgeBio Pharma has scrapped plans to buy out its subsidiary Eidos Therapeutics. The planned deal hit a wall when a special committee set up by Eidos turned down BridgeBio’s third and final offer.